BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Celator Pharmaceuticals, Inc. 

303B College Road East

Princeton  New Jersey  08540  U.S.A.
Phone: 609-243-0123 Fax: 609-243-0202


SEARCH JOBS










 Company News
Celator Pharmaceuticals, Inc. Appoints Jean-Pierre Bizzari To Board Of Directors 3/2/2015 7:52:56 AM
Celator Pharmaceuticals, Inc. To Present At Roth Conference 2/26/2015 9:42:38 AM
Celator Pharmaceuticals, Inc. To Present At Biotechnology Industry Organization (BIO) CEO And Investor Conference 2/2/2015 11:42:59 AM
Celator Pharmaceuticals, Inc. Receives FDA Fast Track Designation For CPX-351 For The Treatment Of Elderly Patients With Secondary Acute Myeloid Leukemia 1/20/2015 6:47:19 AM
Celator Pharmaceuticals, Inc. Announces Publication Of Promising Phase 2 Data For CPX-351 In First Relapse Acute Myeloid Leukemia Patients 1/12/2015 8:16:01 AM
Celator Pharmaceuticals, Inc. Receives $1,937,000 from New Jersey's Technology Business Tax Certificate Transfer Program 1/5/2015 7:10:05 AM
Celator Pharmaceuticals, Inc. Receives European Patent Allowance On Nanoparticle Delivery Technology 12/18/2014 7:50:30 AM
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014 7:51:21 AM
Celator Pharmaceuticals, Inc. Announces Data And Safety Monitoring Board Recommendation To Continue Phase 3 Study Of CPX-351 12/1/2014 8:46:14 AM
Celator Pharmaceuticals, Inc. To Present Data At The 56th American Society of Hematology Annual Meeting 11/24/2014 12:48:20 PM
12345678910...